These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33580646)

  • 1. Risks of controlled substance drug diversion.
    Ash TK; Murray G; Hiler RV
    Am J Health Syst Pharm; 2021 Jun; 78(12):1035-1036. PubMed ID: 33580646
    [No Abstract]   [Full Text] [Related]  

  • 2. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.
    Deyo RA; Irvine JM; Millet LM; Beran T; O'Kane N; Wright DA; McCarty D
    Health Aff (Millwood); 2013 Mar; 32(3):603-13. PubMed ID: 23406570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug diversion administrative revocation and application hearings for medical and pharmacy practitioners: a primer for navigating murky, drug-infested waters.
    Mulrooney JJ; Hull AJ
    Albany Law Rev; 2014-2015; 78(2):101-64. PubMed ID: 25330551
    [No Abstract]   [Full Text] [Related]  

  • 4. New DEA rules expand options for controlled substance disposal.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):22-6. PubMed ID: 25607591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescription drug monitoring programs in the United States of America].
    El Burai Félix S; Mack K
    Rev Panam Salud Publica; 2014 Oct; 36(4):270-6. PubMed ID: 25563153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Paradigm for Providers: Dentists and Pharmacists.
    Park T
    J Calif Dent Assoc; 2015 Nov; 43(11):669-71. PubMed ID: 26798884
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing Prescription Drug Diversion.
    Dumonchelle JV
    J Addict Nurs; 2015; 26(3):109-10. PubMed ID: 26340568
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled Substances Quotas. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Jul; 83(136):32784-90. PubMed ID: 30020581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple Packaging Change Could Help Reduce Drug Diversion.
    Shastay A
    Home Healthc Now; 2018; 36(1):56-58. PubMed ID: 29298201
    [No Abstract]   [Full Text] [Related]  

  • 10. The 2022 ASHP Guidelines on Preventing Diversion of Controlled Substances: An updated roadmap for practice.
    Cobaugh DJ; Maroyka E
    Am J Health Syst Pharm; 2022 Dec; 79(24):2191-2192. PubMed ID: 36382412
    [No Abstract]   [Full Text] [Related]  

  • 11. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverting Data and Drugs: A Narrative Review of the Mallinckrodt Documents.
    Lentacker A; Pham K; Chernesky JM
    J Law Med Ethics; 2024; 52(1):118-132. PubMed ID: 38818605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASHP Guidelines on Preventing Diversion of Controlled Substances.
    Brummond PW; Chen DF; Churchill WW; Clark JS; Dillon KR; Dumitru D; Eschenbacher L; Fera T; Fortier CR; Gullickson KK; Jurakovich K; Kent S; Keonavong J; Marchese C; Meyer T; Murdaugh LB; Ogden RK; O'Neal BC; Rough S; Saenz R; Smith JS
    Am J Health Syst Pharm; 2017 Mar; 74(5):325-348. PubMed ID: 28052859
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing controlled substance diversion in perioperative settings: a narrative review.
    Wong MJ; Wang Y; Blake L; Ke JXC
    Can J Anaesth; 2023 Dec; 70(12):1989-2001. PubMed ID: 37715047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The supply chain of medicinal controlled substances: addressing the Achilles heel of drug diversion.
    Coleman JJ
    J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):233-50. PubMed ID: 22973912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centralizing a controlled substance compliance and drug diversion prevention program within a multihospital health system.
    Neal D; Mitchell L; Mieure K
    Am J Health Syst Pharm; 2023 Jul; 80(15):1018-1025. PubMed ID: 37137529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations.
    Hoefer M; Petrakis I
    Am J Addict; 2014; 23(6):616-7. PubMed ID: 25251308
    [No Abstract]   [Full Text] [Related]  

  • 18. Using Prescription Drug Monitoring Programs to Address Drug Abuse.
    Hansen M
    NCSL Legisbrief; 2015 Mar; 23(12):1-2. PubMed ID: 26173300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(251):96992-7044. PubMed ID: 28068052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of controlled substances in the U.S. supply chain: where does the compass point?
    Ruble JH
    J Pain Palliat Care Pharmacother; 2012 Sep; 26(3):251-3. PubMed ID: 22973913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.